This new report - World Sleep Disorders Market Analysis 2009-2024 - explains the commercial prospects for drugs to treat sleep disorders, an important, changing pharma market.
Online PR News – 23-November-2009 – – Sleep disorders affect hundreds of millions of people worldwide. It is a multi-billion dollar market for drug-based treatments with continuing potential for growth. This new report - World Sleep Disorders Market Analysis 2009-2024 - explains the commercial prospects for drugs to treat sleep disorders, an important, changing pharma market. The principal disorders are insomnia, narcolepsy, sleep apnea and restless leg syndrome, but there are other potentially profitable market segments. Overall, sleep disorders are highly prevalent. Approximately 30% of the population worldwide suffer from sleep disorders analysis suggests. Capturing a segment of this market has enormous potential.
Total drug revenues in the sleep disorders market exceeded $7bn in 2008. Visiongain expects the market to expand during the forecast period 2009-2024 - but by how much? In this new study, you will discover market reach, both worldwide and in major national markets, with leading products and submarkets covered. Growth in the worldwide market will be driven by an increase in the use of insomnia-alleviating and wake-promoting drugs in particular. The treatment of insomnia and some other disorders will change during the forecast period - this report tells you how. An extensive pipeline with new treatment approaches - some close-to-market - will stimulate and increase profitablility in this market sector. A shift from traditional treatments to new drugs will improve treatment options, as well as broadening access to treatments, including use of generic substitutes. New drugs should provide more-attractive treatment options for patients and prescribers who have been deterred by the limitations of existing treatments.
Under-diagnosed and under-treated, sleep disorders present a significant market opportunity for existing and still-to-be-launched treatments. Currently, there is large untapped market potential in the sleep disorder market worldwide. Prescription drugs must compete with OTC products, natural remedies and other treatments, however. Under-treatment is widespread, with many sufferers not seeking medical guidance; that situation should gradually improve, increasing commercial opportunities. The full commercial potential of sleep disorder treatments has thus still to be achieved. The momentum in that sector will increase as companies further invest there, along with healthcare payers worldwide. This new report - Sleep Disorders Market Analysis 2009-2024 - is essential reading for anyone interested in the sleep disorders market. There, you will discover prospects for both existing competitors and potential market entrants from 2009 onwards.
Comprehensive analysis of the sleep disorders market area
Sleep Disorders Market Analysis 2009-2024 examines that market area critically, through a comprehensive review of information sources, both primary and secondary. This report provides detailed sales forecasts, discussions of pipeline developments and analysis of commercial drivers and restraints, including a SWOT analysis. There are many tables and figures included. The result is a comprehensive market- and industry-centred report with detailed analyses and informed opinion to benefit your work.
Why you should buy Sleep Disorders Market Analysis 2009-2024
Benefits from purchasing this report include:
• Your receiving a comprehensive analysis of the prospects for sleep disorder treatments from 2009-2024, including predicted revenues, growth rates and other important data.
• Your accessing forecasts for the top-selling drugs in all the prominent sleep disorder markets, including detailed explanations of factors affecting individual drug sales.
• Your receiving sales forecasts for leading sleep disorder country markets worldwide
• Your identifying key pipeline developments, promising treatment avenues and emerging drug targets.
• Your receiving expert views from our original survey
• Your discovering the important drivers and restraints in the market, and how these operate worldwide
• Your finding out where the market is heading overall - both technologically and commercially - from the present onwards.
There is great untapped potential in the sleep disorder market. Safety and efficacy concerns still limit the commercial potential of sleep disorder drugs, despite the vast potential treatment population - one of the largest in medicine. Some market leaders will soon reach patent expiry. What effects will generic competition have in the market? Will more-effective treatments emerge soon, with commercial gains for innovators? What effects will OTC switching have? This report covers those important questions and many others.
For more information, please visit :
Or email us at firstname.lastname@example.org or call +919272852585